Gavin continues Tumor Takedown Take 2 - ten years since his previous diagnosis with an oligoastrocytoma grade III tumor in February 2014, he had a second surgery to remove new tumor growth and clear radiation activity from the previous resection site. When removed, about 20% of what was there was active disease; the remainder was scar tissue. After attempting a new brain cancer medication that came to market in August 2024 that was unsuccessful, he is now undergoing a second round of radiation and chemo. His updated tumor diagnosis (largely due to tumor classification changing over the past decade) is an IDH Glioma (anaplastic) with a subclass of high grade astrocytoma. Gavin's first tumor was four inches and rested on his left optical nerve. Following radiation and chemo, only a tiny bit (less than a half inch) was left in the resected area. Over the past year, Gavin's oncologist at Northwestern had been monitoring the resection area for what at first appeared to be post-radiation activity - almost a cloud/haze over the resection site. Then there appeared to be increased blood flow to the area suggesting a potential resurgence of tumor growth. The surgery allowed the oncology team to then evaluate what is tumor (and the type) and what is removal of post-radiation. We appreciate any support that will help us focus on time together as a family and helping to alleviate household responsibilities to keep Isaac and Cecilia's lives as normal and consistent as possible.